News
Peptide research news
Recent reporting from peer-reviewed journals, clinical trial readouts, and reputable outlets. Curated by Perplexity, sources cited.
regulatory / BPC-157Promise Launches Clinician-Guided BPC-157 Evaluation as FDA Panel Backs 503A Bulks List Addition
Promise launched a clinician-guided BPC-157 evaluation after an FDA panel backed adding the peptide to the 503A bulks list. The report notes a prior systematic review found 36 studies, mostly preclinical, with only one clinical study.
trial readoutNovo Nordisk says semaglutide cut obesity rates in young children in trial
Novo Nordisk said a late-stage trial in children ages 6 to under 12 found semaglutide met its primary endpoint, with 40.4% no longer classified as having obesity after 68 weeks under full adherence assumptions.
Peptide trial tracker: what is being tested
A peptide trial tracker lists registered studies and enrollment status for peptide and GLP-1 compounds. It is a database-style tracker, not a news article.
Computationally Assisted Peptide Screening to Identify ...
This study identifies optimized peptides that can sustain long-term self-renewal of human pluripotent stem cells without ROCK inhibitors under the tested conditions. It points to a practical strategy for large-scale clinical cell culture applications.
Peptide News — FDA, PubMed & Clinical Trial Updates
This refreshed aggregator surfaces peptide and GLP-1 items from PubMed, FDA MedWatch, and ClinicalTrials.gov. It is useful as a discovery index, though not a primary reporting outlet.
Search Investigations & Research Guides
Aggregates investigations and research guides, including a report that PCAC voted on BPC-157, KPV, TB-500, MOTS-c, semax, and epitalon for the 503A bulks list.
peptide structurePeptides adopt stable omega-loop structures in concentrated sulfuric acid
A study reports that three peptides form stable omega-loop structures in concentrated sulfuric acid, using NMR spectroscopy to characterize compact folded conformations in an extreme solvent environment. The finding expands structural understanding of peptide behavior under highly unusual chemical conditions.
cancer vaccinesSynthetic long peptide and DNA personalized cancer vaccines
This paper describes synthetic long peptide and DNA personalized cancer vaccines, highlighting peptide-based vaccine design in oncology. The work appears in Science Advances and focuses on next-generation immunotherapy approaches.
FDA 503B Outsourcing Facility Inspections: Q1 2026 ...
A Q1 2026 enforcement roundup says FDA issued warning letters, conducted facility inspections, and pursued voluntary recalls involving sterile peptide compounded products.